申请人:McHardy Stanton
公开号:US20050096375A1
公开(公告)日:2005-05-05
The present invention relates to a series of substituted bicyclic[3.1.0]amines of the Formula I:
wherein A, B, D, Q, V, W, X, Y, Z, R
2
, R
3
, R
4
, R
5
, R
14
, R
15
, R
30
. o, p, s,t and q are as defined in the specification, their pharmaceutically acceptable salts, pharmaceutical compositions thereof, and their use for the enhancement of cognition and the treatment of the positive and negative symptoms of schizophrenia and other psychoses in mammals, including humans.
本发明涉及一系列公式I中的取代的双环[3.1.0]胺,其中A、B、D、Q、V、W、X、Y、Z、R2、R3、R4、R5、R14、R15、R30、o、p、s、t和q在说明书中定义,以及它们的药学上可接受的盐,其制药组合物,并且它们的用途是用于增强认知和治疗哺乳动物,包括人类的精神分裂症和其他精神病的阳性和阴性症状。